Cargando…

P1055: BROMODOMAIN AND EXTRA-TERMINAL (BET) INHIBITOR INCB057643 (LIMBER-103) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY MYELOFIBROSIS (R/R MF) AND OTHER ADVANCED MYELOID NEOPLASMS: A PHASE 1 STUDY

Detalles Bibliográficos
Autores principales: Watts, Justin M., Hunter, Anthony M., Iurlo, Alessandra, Xicoy, Blanca, Palandri, Francesca, Reeves, Brandi, Vannucchi, Alessandro, Bose, Prithviraj, Ayala Diaz, Rosa, Halpern, Anna B., Chen, Xuejun, Seguy, Francis, Zhou, Feng, Zheng, Fred, Vachhani, Pankit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431362/
http://dx.doi.org/10.1097/01.HS9.0000971116.17929.06
_version_ 1785091182461714432
author Watts, Justin M.
Hunter, Anthony M.
Iurlo, Alessandra
Xicoy, Blanca
Palandri, Francesca
Reeves, Brandi
Vannucchi, Alessandro
Bose, Prithviraj
Ayala Diaz, Rosa
Halpern, Anna B.
Chen, Xuejun
Seguy, Francis
Zhou, Feng
Zheng, Fred
Vachhani, Pankit
author_facet Watts, Justin M.
Hunter, Anthony M.
Iurlo, Alessandra
Xicoy, Blanca
Palandri, Francesca
Reeves, Brandi
Vannucchi, Alessandro
Bose, Prithviraj
Ayala Diaz, Rosa
Halpern, Anna B.
Chen, Xuejun
Seguy, Francis
Zhou, Feng
Zheng, Fred
Vachhani, Pankit
author_sort Watts, Justin M.
collection PubMed
description
format Online
Article
Text
id pubmed-10431362
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104313622023-08-17 P1055: BROMODOMAIN AND EXTRA-TERMINAL (BET) INHIBITOR INCB057643 (LIMBER-103) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY MYELOFIBROSIS (R/R MF) AND OTHER ADVANCED MYELOID NEOPLASMS: A PHASE 1 STUDY Watts, Justin M. Hunter, Anthony M. Iurlo, Alessandra Xicoy, Blanca Palandri, Francesca Reeves, Brandi Vannucchi, Alessandro Bose, Prithviraj Ayala Diaz, Rosa Halpern, Anna B. Chen, Xuejun Seguy, Francis Zhou, Feng Zheng, Fred Vachhani, Pankit Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431362/ http://dx.doi.org/10.1097/01.HS9.0000971116.17929.06 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Watts, Justin M.
Hunter, Anthony M.
Iurlo, Alessandra
Xicoy, Blanca
Palandri, Francesca
Reeves, Brandi
Vannucchi, Alessandro
Bose, Prithviraj
Ayala Diaz, Rosa
Halpern, Anna B.
Chen, Xuejun
Seguy, Francis
Zhou, Feng
Zheng, Fred
Vachhani, Pankit
P1055: BROMODOMAIN AND EXTRA-TERMINAL (BET) INHIBITOR INCB057643 (LIMBER-103) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY MYELOFIBROSIS (R/R MF) AND OTHER ADVANCED MYELOID NEOPLASMS: A PHASE 1 STUDY
title P1055: BROMODOMAIN AND EXTRA-TERMINAL (BET) INHIBITOR INCB057643 (LIMBER-103) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY MYELOFIBROSIS (R/R MF) AND OTHER ADVANCED MYELOID NEOPLASMS: A PHASE 1 STUDY
title_full P1055: BROMODOMAIN AND EXTRA-TERMINAL (BET) INHIBITOR INCB057643 (LIMBER-103) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY MYELOFIBROSIS (R/R MF) AND OTHER ADVANCED MYELOID NEOPLASMS: A PHASE 1 STUDY
title_fullStr P1055: BROMODOMAIN AND EXTRA-TERMINAL (BET) INHIBITOR INCB057643 (LIMBER-103) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY MYELOFIBROSIS (R/R MF) AND OTHER ADVANCED MYELOID NEOPLASMS: A PHASE 1 STUDY
title_full_unstemmed P1055: BROMODOMAIN AND EXTRA-TERMINAL (BET) INHIBITOR INCB057643 (LIMBER-103) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY MYELOFIBROSIS (R/R MF) AND OTHER ADVANCED MYELOID NEOPLASMS: A PHASE 1 STUDY
title_short P1055: BROMODOMAIN AND EXTRA-TERMINAL (BET) INHIBITOR INCB057643 (LIMBER-103) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY MYELOFIBROSIS (R/R MF) AND OTHER ADVANCED MYELOID NEOPLASMS: A PHASE 1 STUDY
title_sort p1055: bromodomain and extra-terminal (bet) inhibitor incb057643 (limber-103) in patients (pts) with relapsed or refractory myelofibrosis (r/r mf) and other advanced myeloid neoplasms: a phase 1 study
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431362/
http://dx.doi.org/10.1097/01.HS9.0000971116.17929.06
work_keys_str_mv AT wattsjustinm p1055bromodomainandextraterminalbetinhibitorincb057643limber103inpatientsptswithrelapsedorrefractorymyelofibrosisrrmfandotheradvancedmyeloidneoplasmsaphase1study
AT hunteranthonym p1055bromodomainandextraterminalbetinhibitorincb057643limber103inpatientsptswithrelapsedorrefractorymyelofibrosisrrmfandotheradvancedmyeloidneoplasmsaphase1study
AT iurloalessandra p1055bromodomainandextraterminalbetinhibitorincb057643limber103inpatientsptswithrelapsedorrefractorymyelofibrosisrrmfandotheradvancedmyeloidneoplasmsaphase1study
AT xicoyblanca p1055bromodomainandextraterminalbetinhibitorincb057643limber103inpatientsptswithrelapsedorrefractorymyelofibrosisrrmfandotheradvancedmyeloidneoplasmsaphase1study
AT palandrifrancesca p1055bromodomainandextraterminalbetinhibitorincb057643limber103inpatientsptswithrelapsedorrefractorymyelofibrosisrrmfandotheradvancedmyeloidneoplasmsaphase1study
AT reevesbrandi p1055bromodomainandextraterminalbetinhibitorincb057643limber103inpatientsptswithrelapsedorrefractorymyelofibrosisrrmfandotheradvancedmyeloidneoplasmsaphase1study
AT vannucchialessandro p1055bromodomainandextraterminalbetinhibitorincb057643limber103inpatientsptswithrelapsedorrefractorymyelofibrosisrrmfandotheradvancedmyeloidneoplasmsaphase1study
AT boseprithviraj p1055bromodomainandextraterminalbetinhibitorincb057643limber103inpatientsptswithrelapsedorrefractorymyelofibrosisrrmfandotheradvancedmyeloidneoplasmsaphase1study
AT ayaladiazrosa p1055bromodomainandextraterminalbetinhibitorincb057643limber103inpatientsptswithrelapsedorrefractorymyelofibrosisrrmfandotheradvancedmyeloidneoplasmsaphase1study
AT halpernannab p1055bromodomainandextraterminalbetinhibitorincb057643limber103inpatientsptswithrelapsedorrefractorymyelofibrosisrrmfandotheradvancedmyeloidneoplasmsaphase1study
AT chenxuejun p1055bromodomainandextraterminalbetinhibitorincb057643limber103inpatientsptswithrelapsedorrefractorymyelofibrosisrrmfandotheradvancedmyeloidneoplasmsaphase1study
AT seguyfrancis p1055bromodomainandextraterminalbetinhibitorincb057643limber103inpatientsptswithrelapsedorrefractorymyelofibrosisrrmfandotheradvancedmyeloidneoplasmsaphase1study
AT zhoufeng p1055bromodomainandextraterminalbetinhibitorincb057643limber103inpatientsptswithrelapsedorrefractorymyelofibrosisrrmfandotheradvancedmyeloidneoplasmsaphase1study
AT zhengfred p1055bromodomainandextraterminalbetinhibitorincb057643limber103inpatientsptswithrelapsedorrefractorymyelofibrosisrrmfandotheradvancedmyeloidneoplasmsaphase1study
AT vachhanipankit p1055bromodomainandextraterminalbetinhibitorincb057643limber103inpatientsptswithrelapsedorrefractorymyelofibrosisrrmfandotheradvancedmyeloidneoplasmsaphase1study